OncoDNA
PrivateLast Round
Grant
Jan 17, 2024
Total Funding Raised
$35.77M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
OncoDNA is a biotechnology company that provides genomic and theranostic testing services and software to aid oncologists in making personalized treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoDNA Comparables
Compare OncoDNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strata Oncology | 79% | |
| Lucence | 78% | |
| Hedera Dx | 78% | |
OncoDNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 17, 2024 | ||||
| Series C | Jul 3, 2023 | ||||
| Series B | Feb 14, 2020 | ||||
| Series A | Sep 2, 2016 |
Key People
Founding team and executive leadership
OncoDNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series B, Series C |
| Ackermans & van Haaren | Series B, Series C, Series A |
| Verve Ventures | Series B |
| Inventures | Series A, Series B |
| Société Régionale d'Investissement de Wallonie | Series A, Series B |
| Wallonie Entreprendre | Series C |
| Vesalius Biocapital Partners | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 101% MoM, reaching 4.2K.
- Mar 1, 2026
Upcoming launch of 'fragmentomics' liquid biopsy assay in March 2026.
OncoDNA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncoDNA's valuation, stock price, and market status.